Clinical Trials Logo

Clinical Trial Summary

Triptolide has been approve effective in animal model.


Clinical Trial Description

Randomized ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00801268
Study type Interventional
Source Nanjing University School of Medicine
Contact
Status Terminated
Phase N/A
Start date November 2008
Completion date November 2013

See also
  Status Clinical Trial Phase
Completed NCT00491517 - Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety Phase 2
Recruiting NCT05286632 - KidneYou - Innovative Digital Therapy N/A
Active, not recruiting NCT00771888 - Open-Label Extension of LOCKCYST Trial Phase 2/Phase 3
No longer available NCT03717181 - Lixivaptan in a Single Subject With Intractable Pain Due to Polycystic Kidney Disease